Clinical Trial Detail

NCT ID NCT00730158
Title A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements no
Sponsors University of Pittsburgh
Indications

colorectal cancer

Therapies

Irinotecan

KD018

Age Groups: adult

No variant requirements are available.